COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimab: Subgroup analysis in participants with cardiovascular disease and diabetes
2019 ◽
Keyword(s):
2020 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):